Abiopharma

🔍 Fascitelli Michael D (Executive)

Company: VORNADO REALTY TRUST (VNO)

Report Date: 2026-06-17

Detailed Transactions and Holdings:

• Sold 125,350 shares of Common Shares at $36.57 per share (Direct)
  Date: 2026-06-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 483,161.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 8,000 shares of Common Shares at $37.34 per share (Direct)
  Date: 2026-06-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 475,161.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-06-17 | Code: H | nature_of_ownership: Held by May 2025 GRAT | shares_owned_after: 110,980.00 | Footnotes: F1
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-06-17 | Code: H | nature_of_ownership: Held by Nov 2025 GRAT | shares_owned_after: 250,000.00 | Footnotes: F1
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-06-17 | Code: H | nature_of_ownership: Held by LLC | shares_owned_after: 175,878.00 | Footnotes: F1, F4

Footnotes:

• F1: Common shares of beneficial interest, par value $.04 per share (the "Common Shares") of Vornado Realty Trust (the "Company").
• F2: Represents weighted average sale price. These Common Shares were sold at prices ranging from $36.31 to $37.25, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided upon request by the Reporting Person to the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company.
• F3: Represents weighted average sale price. These Common Shares were sold at prices ranging from $37.26 to $37.56, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided upon request by the Reporting Person to the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company.
• F4: Mr. Fascitelli disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mr. Fascitelli is the beneficial owner of these securities for the purpose, except to the extent of the Mr. Fascitelli's pecuniary interest.